PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

Subsidie
€ 2.805.403
2022

Projectdetails

Introduction

The PRISM-LT aims at creating a flexible platform for next generation living tissue manufacturing based on Hybrid Living Materials.

Bio-Ink Design

We plan to design a novel bio-ink where stem cells are integrated in a support matrix enriched with engineered helper cells (either bacteria or yeasts, depending on the application and requirements).

Bioprinting Process

Tuning the operational parameters of the bioprinting process, we will cast down the material controlling the mechanical properties of each voxel. This will result in a 3D patterned structure where stem cells are locally induced to initiate their differentiation towards different lineages.

Stem Cell and Helper Cell Interaction

As far as stem cells proliferate, the helpers remain in a quiescent state. However, when the stem cells get stimulated by the local (printed) mechanics and enter a differentiation pathway, they start secreting a pool of lineage-specific metabolites.

The helper cells are designed to:

  1. Sense these early markers of differentiation.
  2. Respond by producing in-situ the corresponding growth factors, providing the relevant chemical guidance.

Helper cells within the platform amplify the initial lineage commitment in each area and dynamically sustain differentiation on a longer term.

Project Implementation

During the project, we will implement this strategy and develop two independent symbiotic materials, targeting biomedical and food applications, respectively.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.805.403
Totale projectbegroting€ 2.805.403

Tijdlijn

Startdatum1-11-2022
Einddatum31-10-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • IN SRL IMPRESA SOCIALEpenvoerder
  • CHALMERS TEKNISKA HOGSKOLA AB
  • STICHTING RADBOUD UNIVERSITEIT
  • BICO GROUP AB
  • CELLINK BIOPRINTING AB
  • UNIVERSIDADE DE AVEIRO
  • UNIVERSITY OF GLASGOW

Land(en)

ItalySwedenNetherlandsPortugalUnited Kingdom

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"

The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.

€ 2.996.550
EIC Pathfinder

Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.

The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.

€ 2.744.300
EIC Pathfinder

Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures

Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.

€ 2.552.277
EIC Pathfinder

Emerging technologies for crystal-based gamma-ray light sources

TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.

€ 2.643.187

Vergelijkbare projecten uit andere regelingen

ERC POC

A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow

The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.

€ 150.000
ERC STG

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

€ 1.499.906
ERC POC

Human based bioinks to engineer physiologically relevant tissues

HumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing.

€ 150.000
ERC STG

Jam with the flow: Microgel-based (bio)inks that assemble during printing

Developing microgel-based materials for extrusion-based 3D printing to create stable, heterogeneous scaffolds with precise control over local properties for biomedical applications.

€ 2.075.000